7[1]Audet. PH., Lamb Y, Jorkasky D, et al. Effect of multiple doses of epristends, a steroid 5a- reductase inhibitor, on serum dihydrotestos- terone in older male subjects. Clin Pharmacol Ther, 1993; 53: 231.
8[2]Johnsonbaugh RE, Cohen BR, McCormack, EM, et al. Effect of fourteen days treatment with epristeride, an uncompetitive 5a- reductase inhibitor. on serum and prostatic testosterone and dihydrotestosterone in men with benign prostatic hyperpiasia. J Urol, 1993; 149: 423a.
9[3]Depre M, Meeter C, Hecken AV, et al. Pharmacodynamics and tolerability of L-654,066, a steroid 5a- reductase inhibitor, in men. Clin Pharmacol Ther, 1992; 52: 409～412.
10[4]Boppana VB, et al. Normal - phase high performance liquid chromto- graphic determination of epristeride, a prestatic steroid 5a- reductase enzyme inhibitor, inhuman plasma. J Chromatogr, 1993; 631: 251～254.
